Skip to content
StockMarketAgent
Direct answer
Coca-Cola Europacific Partners (CCEP) is an entrenched, high-quality bottler generating roughly $2 billion in annual free cash flow. While it operates with structurally lower margins than franchisors like KO, its local monopoly on distribution and vast scale provide a wide economic moat. It is a predictable compounder actively returning capital through dividends and buybacks. Fair value range: low $91.3, high $140, with mid-point at $116.
Stock analysis

CCEP fair value $91–$140

By StockMarketAgent.AI team· supervised by
تحلیل شد: 2026-05-20به‌روزرسانی بعدی: 2026-08-20Methodology v2.4Data cut-off: Quality gate: passSources: all material sources passed deterministic freshness/provenance gatesReview: automatedArchetype: Mature compounder
View archive
قیمت
$91.86
▲ +23.88 (+26.00%)
ارزش منصفانه
$116
$91–$140
رتبه‌بندی
خرید قوی
confidence 88/100
پتانسیل رشد
+26.0%
upside to fair value
حاشیه ایمنی
$98.38
MoS level · 15%
ارزش بازار
$40.7B
P/E fwd 16.2
منبع انگلیسیFA
منبع انگلیسی تا زمان ترجمه نمایش داده می‌شود
این گزارش هنوز ترجمه نشده است. پس از چند دقیقه، زمانی که صف ترجمه به‌روز شد، صفحه را تازه کنید.

§1 خلاصه اجرایی

  • Defensive consumer staples compounder producing $2B+ in annual free cash flow.
  • Trading at a steep discount to structural moat-fade intrinsic value of $115.74.
  • Market implicitly prices zero-to-negative volume growth, ignoring durable ROIC.
  • Stable 13.3% operating margins prove successful pass-through of severe cost inflation.
Fair value
$116
Margin of safety
+20.6%
Confidence
88/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$91.86Price
Low $91.30
Mid $115.74
High $140.15

Coca-Cola Europacific Partners (CCEP) is an entrenched, high-quality bottler generating roughly $2 billion in annual free cash flow. While it operates with structurally lower margins than franchisors like KO, its local monopoly on distribution and vast scale provide a wide economic moat. It is a predictable compounder actively returning capital through dividends and buybacks.

  • Exclusive territorial distribution agreements for
    Exclusive territorial distribution agreements for top global beverage brands.
  • Massive local distribution density creating
    Massive local distribution density creating insurmountable scale advantages.
  • Cycle upside
    Normalized supply chains and highly stable consumer staples demand driving margin expansion.

§2 سناریوی نزولی

Consumer elasticity reaches a tipping point amid sticky wage and packaging inflation, compressing operating margins back toward 10% and stunting free cash flowFree cash flowOperating cash flow minus capital expenditures. The cash a business generates after maintaining and growing its asset base — the closest accounting proxy for owner-economics. generation.

چگونگی شکست این تز

Elasticity Breakpoint

· Medium

Consumers reject sustained price hikes, driving permanent volume declines and private label substitution.

FV impact
Downside to $91.30
Trigger
12-24 Months

Franchisor Margin Extraction

· Low

Primary franchisor aggressively hikes concentrate pricing, forcing the bottler to absorb the margin compression.

FV impact
Sub-$80s Valuation
Trigger
24-36 Months

Capital Intensity Spike

· Low

Maintenance capex-to-D&A structurally rises above 1.2x, permanently impairing free cash flow conversion.

FV impact
15% Intrinsic Value Reduction
Trigger
36+ Months
سیگنال‌های هشدار اولیه برای پایش
معیارفعلیآستانه فعال‌سازی
Operating margins compress below 12.0% for two consecutive quarters.MonitorDeterioration versus the report thesis
Maintenance capex-to-D&A structurally rises above 1.2x.MonitorDeterioration versus the report thesis
Volume declines exceed low-single digits despite flat macro environment.MonitorDeterioration versus the report thesis
Adverse shifts or renegotiations in franchisor territorial agreements.MonitorDeterioration versus the report thesis
Free cash flow conversion drops permanently below historical $2B baseline.MonitorDeterioration versus the report thesis

§3 تاریخچه مالی

صورت سود و زیان — شش دوره اخیر
ردیفT−0T−1T−2T−3نرخ رشد سالانه مرکب
دوره2022-12-312023-12-312024-12-312025-12-31Trend
درآمد$17.32B$18.30B$20.44B$20.90B+6.5%
سود ناخالص$6.22B$6.72B$7.21B$7.44B+6.1%
سود عملیاتی$2.23B$2.33B$2.54B$2.79B+7.7%
سود خالص$1.51B$1.67B$1.42B$1.94B+8.8%
EPS (رقیق‌شده)$3.29$3.63$3.08$4.26+9.0%
EBITDA$2.94B$3.16B$3.11B$3.77B+8.7%
تحقیق و توسعه
هزینه‌های عمومی و فروش$1.99B$2.20B$2.35B$2.35B+5.8%

امتیازات کیفیت

امتیاز Piotroski F
7 / 9
ترکیب کیفیت ۰–۹
امتیاز Altman Z
2.5
ریسک ورشکستگی (>۳ ایمن)
امتیاز Beneish M
-2.61
ریسک دستکاری سود
OCF / سود خالص
1.52×
>۱ نشان‌دهنده کیفیت بالای سود
دروازه کیفیت حسابداری
Pass
دروازه تعدیل‌شده بخشی
ROIC
12.1%
بازده سرمایه‌گذاری‌شده
بخش ۳

Numbers analysis

جریان نقدی

Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.

تخصیص سرمایه

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

مشترکان فردی — از §۴ به بعد11 بخش بیشتر

تحلیل کامل را بخوانید — 11 بخش بیشتر.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

گزارش کامل برای هر نماد تحت پوشش
بایگانی ۲۴ ماه رتبه‌بندی
بریفینگ‌های فهرست مشاهده + هشدارهای تغییر رتبه
خروجی PDF + DOCX به هر زبان
شروع آزمایش رایگان
قابل لغو در هر زمان.
FAQ

CCEP — frequently asked questions

  1. Based on our latest analysis, CCEP looks meaningfully undervalued. The current price is $91.9 versus a composite fair-value midpoint of $116 (range $91.3–$140), which implies roughly 26.0% upside to the midpoint.
Related coverage

Names readers of CCEP also follow

Same archetype: mature-compounder